Tavio Capital LLC - Q4 2017 holdings

$183 Million is the total value of Tavio Capital LLC's 8 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 80.0% .

 Value Shares↓ Weighting
ABC NewAMERISOURCEBERGEN CORP$35,323,000384,697
+100.0%
19.27%
ANTM SellANTHEM INC$30,276,000
-39.4%
134,554
-48.9%
16.52%
-18.7%
UHS BuyUNIVERSAL HLTH SVCS INCcl b$26,862,000
+18.3%
236,979
+15.8%
14.66%
+58.6%
MOH SellMOLINA HEALTHCARE INC$25,362,000
-31.3%
330,747
-38.4%
13.84%
-7.9%
CVS NewCVS HEALTH CORP$24,471,000337,537
+100.0%
13.35%
BSX SellBOSTON SCIENTIFIC CORP$19,680,000
-60.2%
793,865
-53.1%
10.74%
-46.6%
DVA NewDAVITA INC$15,110,000209,130
+100.0%
8.24%
RTRX  RETROPHIN INC$6,193,000
-15.3%
293,9230.0%3.38%
+13.5%
TDOC ExitTELADOC INC$0-160,011
-100.0%
-2.16%
XBI ExitSPDR SERIES TRUSTs&p biotech$0-115,821
-100.0%
-4.08%
SPY ExitSPDR S&P 500 ETF TRtr unit$0-55,000
-100.0%
-5.62%
MCK ExitMCKESSON CORP$0-140,372
-100.0%
-8.77%
CNC ExitCENTENE CORP DEL$0-296,731
-100.0%
-11.68%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLINA HEALTHCARE INC13Q2 202029.6%
CENTENE CORP DEL11Q2 202019.1%
ANTHEM INC10Q2 201922.5%
BOSTON SCIENTIFIC CORP9Q4 201920.9%
RETROPHIN INC9Q1 20193.4%
ZIMMER BIOMET HOLDINGS INC8Q2 202020.6%
HUMANA INC8Q4 201937.8%
UNIVERSAL HLTH SVCS INC8Q1 201914.7%
HCA HEALTHCARE INC8Q1 202012.3%
MCKESSON CORP7Q2 202023.1%

View Tavio Capital LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2020-10-01
13F-HR2020-08-13
13F-HR2020-05-14
13F-HR2020-02-13
13F-HR2019-11-13
13F-HR2019-08-13
13F-HR2019-05-14
13F-HR2019-02-14
13F-HR2018-11-13
13F-HR2018-08-13

View Tavio Capital LLC's complete filings history.

Compare quarters

Export Tavio Capital LLC's holdings